Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 78
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06689254 | REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism | ||
| NCT04795479 | T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers | ||
| NCT02642939 | Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT07259317 | Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma | ||
| NCT06928779 | Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant | ||
| NCT03877562 | The Effect of CORT118335 on Olanzapine-Induced Weight Gain | ||
| NCT03878264 | Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants | ||
| NCT00146523 | An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT03442621 | Relacorilant Food Effect Study in Healthy Subjects | ||
| NCT06094725 | A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant | ||
| NCT03315338 | First-in-human Study in Healthy Subjects | ||
| NCT00752843 | A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers | ||
| NCT02804750 | Study to Evaluate CORT125134 in Participants With Cushing's Syndrome | ||
| NCT00637494 | A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features | ||
| NCT04672499 | Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants | ||
| NCT00128479 | A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT03512548 | Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites | ||
| NCT06906341 | Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers | ||
| NCT00130676 | A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT00796783 | A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia | ||
| NCT02663609 | Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome | ||
| NCT06108219 | A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) | ||
| NCT04588688 | Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency | ||
| NCT06094790 | A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects | ||
| NCT04990310 | Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants | ||
| NCT04373265 | Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | ||
| NCT04994743 | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants | ||
| NCT03540836 | A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants | ||
| NCT06099769 | A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer | ||
| NCT05347979 | Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants | ||
| NCT03508635 | CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT05772169 | Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) | ||
| NCT06829537 | Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM) | ||
| NCT05217758 | RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma | ||
| NCT05003713 | Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants | ||
| NCT07276373 | Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies | ||
| NCT05117489 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT04249323 | Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants | ||
| NCT03259542 | Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor | ||
| NCT04329949 | Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT00936741 | An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT03437941 | Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC | ||
| NCT00128505 | An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression | ||
| NCT02922257 | Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery | ||
| NCT03457597 | Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s | ||
| NCT00569582 | A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT04524403 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) | ||
| NCT00455442 | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain | ||
| NCT03818256 | A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications | ||
| NCT01925092 | Mifepristone in Children With Refractory Cushing's Disease |
